# Study Evaluating Etanercept in Patients With Ankylosing Spondylitis

> **NCT00458185** · PHASE4 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 40 (actual)

## Conditions studied

- Ankylosing Spondylitis

## Interventions

- **DRUG:** etanercept

## Key facts

- **NCT ID:** NCT00458185
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** —
- **Final completion:** 2007-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2008-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00458185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00458185, "Study Evaluating Etanercept in Patients With Ankylosing Spondylitis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00458185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*